Stevanato Group SpA
NYSE: STVN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
Updated 2026-06-05
Stevanato Group SpA (STVN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $781.58M | $882.18M | $967.98M | $1.42B | $1.66B | $2.07B | $2.33B | $2.54B |
| Cash & equivalents | $74.52M | $85.39M | $115.60M | $411.04M | $228.74M | $69.60M | $98.27M | $130.54M |
| Current assets | $394.88M | $449.58M | $492.77M | $865.97M | $845.77M | $861.89M | $880.12M | $934.40M |
| Total liabilities | $550.18M | $616.74M | $657.84M | $577.18M | $663.79M | $938.93M | $924.43M | $1.06B |
| Current liabilities | $243.91M | $262.94M | $316.18M | $338.62M | $462.50M | $574.39M | $477.47M | $535.57M |
| Long-term debt | $245.19M | $284.18M | $273.94M | $183.99M | $133.75M | $242.05M | $305.23M | $337.78M |
| Shareholder equity | $231.56M | $265.49M | $310.50M | $842.07M | $996.13M | $1.13B | $1.40B | $1.49B |
| Retained earnings | — | $287.33M | $355.61M | $27.00M | $623.35M | $757.86M | $863.44M | $876.41M |
| Accounts receivable | $181.04M | $160.58M | $167.25M | $278.42M | $369.48M | $522.48M | $529.87M | $542.17M |
| Inventory | $98.61M | $131.88M | $139.37M | $148.92M | $213.25M | $255.32M | $245.22M | $268.09M |
| Goodwill | $47.24M | $47.24M | $47.24M | $47.24M | $47.24M | $49.98M | $49.98M | $49.96M |
Frequently asked questions
What is Stevanato Group SpA's revenue?
Stevanato Group SpA's trailing twelve-month revenue is $1.20B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is STVN?
In its most recent fiscal year, STVN ran a gross margin of 28.99%, an operating margin of 16.07%, and a net margin of 11.78%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does STVN generate?
STVN produced $21.44M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is STVN's balance sheet healthy?
STVN holds $130.54M in cash and equivalents against $337.78M in long-term debt, on $1.49B of shareholder equity. That debt is best read against the cash flow the business throws off each year.